Dow Up1.31% Nasdaq Up2.40%

Biogen Idec Inc. (BIIB)

-NasdaqGS
326.77 Up 15.36(4.93%) 4:00PM EDT
|After Hours : 330.00 Up 3.23 (0.99%) 7:57PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 2,421,452   2,129,751   1,965,850   1,827,780  
Cost of Revenue291,887  279,245  258,553  234,696  
Gross Profit 2,129,565   1,850,506   1,707,297   1,593,084  
Operating Expenses
Research Development447,273  528,884  422,233  410,017  
Selling General and Administrative580,641  510,875  525,293  405,487  
Non Recurring -   -   -   -  
Others116,826  143,258  109,424  99,998  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 988,725   671,348   657,926   684,531  
Income from Continuing Operations
Total Other Income/Expenses Net8,761  (1,742)2,174  2,309  
Earnings Before Interest And Taxes997,486  669,606  660,100  686,840  
Interest Expense -   -   -   -  
Income Before Tax997,486  669,606  660,100  686,840  
Income Tax Expense268,521  178,414  190,261  186,105  
Minority Interest(8,626)228   -   -  
Net Income From Continuing Ops718,406  483,815  464,885  494,565  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 714,506   479,956   457,306   487,616  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 714,506   479,956   457,306   487,616  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.